key: cord-0882401-wz7mbhsb
authors: Rodrigues, Felipe Tavares; Quirino, Renata Miguel; Gripp, Alexandre Carlos
title: Cutaneous and pulmonary manifestations of sarcoidosis triggered by coronavirus disease 2019 infection
date: 2022-04-08
journal: Rev Soc Bras Med Trop
DOI: 10.1590/0037-8682-0647-2021
sha: b8f1be06d5c428f7fec88d895d0a3084032bdad9
doc_id: 882401
cord_uid: wz7mbhsb

nan

The coronavirus disease 2019 (COVID-19) can cause dermatological manifestations such as urticarial rash, confluent erythematous/maculopapular/morbilliform rash, papulovesicular exanthema, chilblain-like acral pattern, livedo reticularis/ racemosa-like patterns, and purpuric "vasculitic" patterns 1 .

Herein, we describe a case of sarcoidosis with exuberant cutaneous and pulmonary manifestations after recovery from COVID-19 infection. In the literature, only two cases of granulomatous sarcoid-like reaction have been described, with few lesions and no pulmonary involvement of the disease 2 .

A 57-year-old woman with no previous comorbidities was admitted to the dermatology department with erythematous, symmetrical, non-pruritic papules and plaques; some had an annular disposition over six months of evolution (Figures 1A-D) . The patient had a persistent dry cough for three months. The first lesions appeared about 20 days after the patient presented with symptoms of flu syndrome (fever, runny nose, headache, fatigue, and anophthalmia), and they did not require hospitalization. A nasal swab test with polymerase chain reaction confirmed a SARS-CoV-2 infection. The diagnosis of sarcoidosis was confirmed via skin biopsy (Figure 1F and 1G) . Chest computed tomography (CT) revealed pulmonary involvement ( Figure 1E) . The tuberculin test result was negative, and the patients' serum calcium levels were slightly above the normal limits. We started treatment with 60 mg prednisone plus 100 mg azathioprine per day, which improved the patient's symptoms.

There may be an intrinsic relationship between viral infections and sarcoidosis development in genetically susceptible hosts 3 .

Skin Manifestations Associated with COVID-19: Current Knowledge and Future Perspectives

Sarcoid-like reaction in a patient recovering from coronavirus disease 19 pneumonia

Viral-induced inflammation in interstitial lung diseases

We offer our deepest thanks to the institutions that provided technical support for the development and implementation of this study.